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Summary
Introduction: We report here two cases of Agrobacterium radiobacter bacteremia. These cases
were observed at the same institution over a short time period (3 months).
Case reports: The first patient was a female cancer patient receiving third-line chemotherapy for
ovarian carcinoma. When she developed bacteremia, she was neutropenic and had an indwelling
catheter that was removed as part of the treatment. The second case was a geriatric patient
admitted from home with bacteremia, clinical signs of septic shock, and concomitant acute
cholecystitis.
Outcome: Both patients responded promptly and completely to antibiotherapy. No recurrence
was observed.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Agrobacterium radiobacter is an agricultural soil bacterium
that survives in the ground as a saprophytic organism. It is a
Gram-negative aerobic bacillus that can be an opportunistic
pathogen, often associated with indwelling catheter infec-
tion.1,2 Predisposing factors are leukopenia, neutropenia,
low CD4+ lymphocyte count, hospitalization, concurrent
AIDS-related infectious complications, indwelling catheter,
and instrumentation.3* Corresponding author. Tel.: +32 71 93 47 00; fax: +32 71 93 47 05.
E-mail address: dhondt.lionel@chndrf.be (L. D’Hondt).
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doi:10.1016/j.ijid.2008.03.010A. radiobacter bacteremia has most frequently been
reported in the HIV-infected population, but recently cases
in other compromised patients have been published. Onco-
logic and geriatric patients belong to this last category. In this
population, bacteremia is also frequently due to an indwel-
ling catheter infection. We report here a single institution’s
experience of two cases of A. radiobacter bacteremia. These
two cases were observed over a short time period (3 months)
on two different hospital wards. In one patient, the catheter
was believed to be the cause of infection, while for the
second, the origin remained obscure. We discuss here the
epidemiology and characteristics of A. radiobacter infections
in the light of our two cases.Published by Elsevier Ltd. All rights reserved.
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In December 2001, a 42-year-old woman was diagnosed with
FIGO (Fe´de´ration Internationale de Gyne´cologie et d’Obste´-
trique) stage IV ovarian carcinoma. She underwent debulking
surgery followed by multiple lines of chemotherapy treat-
ment. The first line consisted of six courses of carboplatin
(area under the curve (AUC) 6) and taxol 175 mg/m2 admi-
nistered every 3 weeks. For this treatment, a Bard Port1
indwelling catheter was placed. In December 2002, CA-125
started to rise and peritoneal carcinomatosis was diagnosed.
A second treatment with topotecan (1.25 mg/m2 for 5 days
every 3 weeks) was started. In October 2003, a new che-
motherapy was started with carboplatin (AUC 6) and Caelyx1
(30 mg/m2 every 4 weeks) due to a third increase of CA-125
with peritoneal relapse. In November 2003 while perfusing
the port for a routine post-chemotherapy blood control, she
presented malaise, fever, and shivers. Physical examination
was normal with the exception of a high body temperature
(39 8C). There was no sign of septic shock and these symp-
toms lasted 48 hours. Her white blood cell count on admission
was 1.96  109/l, with 51.5% neutrophils (1  109/l), 38.8%
lymphocytes (0.8  109/l), and 9.7% monocytes (0.2  109/
l). C-reactive protein (CRP) was 1.9 mg/dl (normal <1 mg/
dl). She was treated empirically with intravenous (IV) cefta-
zidime (2 g/8 h) and rapidly became afebrile. The antimi-
crobial susceptibility to antibiotics was determined before
definitive identification of the pathogen. It showed sensitiv-
ity to third-generation cephalosporins, beta-lactams, carba-
penems, amikacin, ciprofloxacin, meropenem, and co-
trimoxazole. The identification of the pathogen came later:
three blood samples obtained one through the port and two
through peripheral veins were positive for A. radiobacter.
The identification of A. radiobacter was confirmed in a
bacteriology reference laboratory. The port was suspected
to be the origin of the infection and was then removed after 7
days of IV antibiotic treatment (ceftazidime 2 g/8 h). A
culture of the removed port remained sterile. A total of 10
days of IV ceftazidime was administered, then the patient
was discharged with oral ciprofloxacin. Three weeks after
oral antibiotherapy, a new port was implanted and che-
motherapy was continued. To-date no further infection has
been observed in this patient.
Case 2
An 80-year-old man was hospitalized for fainting, high fever,
septic shock, and acute renal failure. He was living at home
and had a history of epilepsy, stroke, gastric hemorrhage,
chronic renal failure, and bladder catheter for prostate
hypertrophy. Physical examination revealed signs of septic
shock with a blood pressure of 100/70 mmHg, tachycardia
108 beats per minute, and peripheral cyanosis. His body
temperature was 38.8 8C. There was tenderness with a
rebound in the right upper quadrant. Laboratory tests
showed: 11.2  109/l leukocytes with 81% neutrophils, CRP
10 mg/dl, and moderately increased liver enzymes. Com-
puted tomography of the abdomen showed an acute chole-
cystitis without signs of biliary tract enlargement. Urine
culture obtained through the bladder catheter remained
sterile, while three blood cultures showed the presence ofA. radiobacter. IV ciprofloxacin (800 mg per day), metroni-
dazole (1500 mg per day), and amikacin (1 g on day 1 fol-
lowed by 500 mg once daily) were empirically started.
Antibiotherapy was not modified, except that metronidazole
was stopped when the pathogen was identified since this was
sensitive to most usual antibiotics except aztreonam. In
addition, the medical evolution was favorable: amikacin
was stopped after 5 days and ciprofloxacin IV after 10 days.
At day 11 the patient was discharged with oral ciprofloxacin
(1 g daily) for an additional 3 weeks. He then underwent an
elective laparoscopic cholecystectomy. At microscopic eva-
luation there were signs of residual acute cholecystitis. Gall
culture remained sterile. The bladder catheter was not
changed and there was no recurrence of A. radiobacter
bacteremia.Discussion
A. radiobacter is an environmental bacterium present in
rhizospheres. It is a motile, glucose non-fermenting, Gram-
negative bacillus, oxidase positive, strongly urease positive,
and able to hydrolyze esculin.4 It is an active carbohydrate
oxidizer. This bacterium is mostly encountered in soils and
plants.5 Isolation in clinical specimens is very rare. A. radio-
bacter can be distinguished from other species — Agrobac-
terium rhizogenes, Agrobacterium rubi, and Agrobacterium
tumefaciens — as the only one that has been described not
only as a plant pathogen but also as a human pathogen,
although of low virulence. However, a case of A. tumefaciens
bacteremia has recently been reported.6 In the literature,
about 40 cases of infection with A. radiobacter have been
recorded. More than half of the patients presented with
bacteremia, peritonitis, urinary tract infection, endocardi-
tis, or cellulitis.7,8 Immunosuppression, the presence of cen-
tral venous catheters, nephrostomy tubes, intraperitoneal
catheters, and prosthetic valves were predisposing factors.
The first-line antibiotic therapy for A. radiobacter disease
has not been definitively determined. The vast majority of
reported patients responded to different antimicrobial
therapies, and this strategy was often combined with
removal of suspected catheters.9
The antimicrobial susceptibility patterns of these organ-
isms appear to be quite variable.8 In different reports, cure
was obtained with a wide range of different antimicrobial
agents including: association of beta-lactams plus aminogly-
cosides, co-trimoxazole and imipenem, ampicillin or beta-
lactams associated with beta-lactamase inhibitors, third
generation cephalosporins, imipenem, co-trimoxazole, and
fluoroquinoles alone. Alnor et al. suggested that ciproflox-
acin be the first choice.4 These reports came mostly from
observations in HIV-infected patients. The outcome of infec-
tion was favorable in all cases described, and no direct
mortality was observed.
If most observations were reported in HIV-infected
patients, the isolation of A. radiobacter in oncologic patients
is, however, uncommon. In the literature, Paphitou and
Rolston recently reported a case of catheter-related bacter-
emia due to A. radiobacter in a neutropenic patient.10
Castagnola et al. reported other cases in a population of
children with Broviac1 catheters for cancer treatment.11
Children were receiving antineoplastic chemotherapy or
Agrobacterium radiobacter bacteremia e9bone marrow transplantation, and all episodes were diag-
nosed in the absence of granulocytopenia. In addition,
Amaya and Edwards reported A. radiobacter bacteremia
in five pediatric patients. All cases were related to catheter
infection.12 Hammerberg et al. described the isolation
of A. radiobacter from a central venous catheter in a
patient undergoing chemotherapy who had been neutrope-
nic.1 Dunne et al. reported infection with A. radiobacter
that was isolated in blood cultures from an immunocompro-
mised child cancer patient who had a transcutaneous
catheter.13
Gram-positive bacteria are most frequently responsible
for indwelling catheter infections, however other pathogens
can be found, particularly in neutropenic patients, for
instance: yeasts, fungi, Gram-negative bacilli, and coryne-
bacteria. In oncologic patients some criteria are important
to judge the severity of infections: the location of infection,
the catheter device (central venous catheter or port), and
the gravity of symptoms (septic shock or not). The eradica-
tion of the infection from the chamber of the indwelling
catheter is more difficult and the principle of treatment in
this kind of infection is antibiotherapy and removal of the
catheter.9
In the second case, we observed A. radiobacter bacter-
emia in a man who was not being treated for cancer.
However he could be considered an immunocompromised
patient since he was old and suffered from chronic renal
failure. In addition, he had a permanent bladder catheter.
We discovered concomitantly to the bacteremia an acute
cholecystitis, probably secondary to the systemic infection.
The cholecystitis was later histologically confirmed when
the gallbladder was removed by elective surgery. The origin
of the bacteremia was not found, but it is of note that the
urine remained sterile and that the infection never
recurred despite the fact that we did not change the
bladder catheter. An interesting point is the fact that
the patient was admitted from home when the bacteremia
was diagnosed. Unfortunately the personal habits of this
patient were not recorded in order to determine a possible
risk behavior.
A. radiobacter bacteremia has rarely been described in
the geriatric population. Our second case suggests that
despite not being severely immunosuppressed by HIV infec-
tion or cancer treatments, the geriatric population, fre-
quently suffering from multiple organ dysfunction, can be
prone to develop infections due to this pathogen. In 1985
Freney et al. presented the case of an elderly patient receiv-
ing artificial ventilation who developed A. radiobacter bac-
teremia.14 This patient was the second case of A. radiobacter
human infection ever reported, and unfortunately the source
of infection was not found. More recently Yu et al. described
a 78-year-old patient with chronic obstructive pulmonary
disease treated with corticosteroids who developed A. radio-
bacter bacteremia in the intensive care unit.15 Finally, a
patient with corticosteroid use and diabetes mellitus who
developed A. radiobacter bacteremia has recently been
published.16
In a larger published series of 13 patients with A. radio-
bacter bacteremia, Lai et al. reported that 76% of patients
(10 patients) had underlying hematological malignancy or
solid-organ cancer. Six patients (46%) had febrile neutro-
penia and most of the infections were catheter-related(54%). Finally 92% of infections were hospital-acquired,
although not due to nosocomial spread, and all patients
survived.17
On at least one occasion pseudobacteremia with A. radio-
bacter has been reported. These false-positive blood cultures
collected in newborns were due to an environmental source
and faulty blood inoculation techniques.18
In conclusion, A. radiobactermay play a pathogenic role in
oncologic patients, especially if indwelling devices are pre-
sent. In addition the geriatric population with its possible
multi-organ dysfunction can be vulnerable to this pathogen.
Complete cure can be achieved with appropriate antibiotics
and removal of the infected catheter.9 The prognosis of the
infection is usually good.17
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